Can hydrocortisone be administered intravenously to infants younger than one year of age?

Hydrocortisone IV in Infants Under 1 Year Old

Yes, hydrocortisone IV can be safely administered to infants under 1 year of age using weight- or body-surface-area-based dosing for appropriate indications including adrenal crisis, adrenal insufficiency, and septic shock. 1

Dosing Regimens for Infants <1 Year

Acute Adrenal Crisis

• Weight-based bolus: Administer 25 mg IV or IM for infants ≤15 kg as an immediate bolus 1, 2
• Maintenance therapy: Follow with 50–100 mg/m²/day divided every 6 hours IV or as continuous infusion 1
• Fluid resuscitation: Give 0.9% saline bolus 20 mL/kg (can repeat up to total 60 mL/kg if shock persists) 1
• Hypoglycemia management: Add dextrose 0.5–1 g/kg or 5–10 mL/kg of D10W for infants 1

Chronic Maintenance Therapy

• Neonates (first month): 20–40 mg/m²/day hydrocortisone divided into 3 doses 2
• Infants 1–12 months: 8–15 mg/m²/day for primary adrenal insufficiency 2
• Mineralocorticoid support: Add fludrocortisone 50–100 µg/day plus oral sodium chloride 1–2 g/day (≈17–34 mmol) due to renal mineralocorticoid resistance in infants 2

Septic Shock

• Dosing: 2 mg/kg hydrocortisone every 6–8 hours IM/SC or every 6 hours IV 2
• Duration: Continue for ≥3 days at full dose 2

Critical Monitoring Requirements

Infants require more intensive monitoring than older children due to developmental physiology: 1

• Frequency: Assess every 3–4 months minimum during the first year of life 1
• Blood pressure: Monitor especially closely during first year due to increasing mineralocorticoid sensitivity 1
• Growth parameters: Track weight and length at each visit 1
• Electrolytes: Regular sodium and potassium monitoring 2
• Blood glucose: Watch for hypoglycemia, particularly relevant in infants 1

Safety Considerations Specific to Infants

Growth Suppression Risk

• Doses >20 mg/m²/day in infants are associated with growth suppression and reduced adult height 2
• Growth velocity is the most sensitive indicator of excess glucocorticoid exposure, more so than HPA axis testing 3
• Titrate to the lowest effective dose to minimize growth effects 3

Infection Risk

• Disseminated candidal infections: IV hydrocortisone significantly increases risk in preterm infants <35 days of age (7.5-fold increased risk) 4
• Consider this risk particularly in extremely premature infants requiring prolonged IV access and broad-spectrum antibiotics 4

Dosing Pitfalls in Premature Infants

• Higher initial doses (>2 mg/kg/day) are independently associated with increased mortality in extremely premature infants (aOR 3.27,95% CI 2.47–4.34) 5
• For premature infants with hypotension or bronchopulmonary dysplasia prevention, use lower-dose regimens when possible 5

Evidence Quality & Guideline Strength

The Endocrine Society (2016) provides strong recommendations (1QQQE) for hydrocortisone use in pediatric adrenal crisis with age-appropriate dosing. 1 The guidelines explicitly include infants in their dosing tables and recommendations, with specific weight-stratified regimens (25 mg for infants in the unable-to-tolerate-oral-medication scenario). 1

The FDA label confirms hydrocortisone sodium succinate permits immediate IV administration and is rapidly absorbed, with effects evident within one hour. 3 The label notes that pediatric efficacy and safety are based on well-established effects similar to adults, with published evidence supporting use in infants >1 month of age for specific indications. 3

Practical Algorithm for Infant Dosing

1. Calculate body surface area (BSA) using standard nomograms or formulas
2. For adrenal crisis: Give 25 mg IV/IM bolus immediately, then 50–100 mg/m²/day divided q6h 1, 2
3. For maintenance: Start 20–40 mg/m²/day in neonates or 8–15 mg/m²/day in older infants, divided TID 2
4. Add mineralocorticoid: Fludrocortisone 50–100 µg/day plus sodium supplementation 1–2 g/day in infants 2
5. Monitor closely: BP, growth, electrolytes every 3–4 months minimum 1

Common Pitfalls to Avoid

• Do not delay treatment in suspected adrenal crisis waiting for laboratory confirmation 1
• Do not use adult fixed doses (e.g., 100 mg) in small infants; always calculate weight- or BSA-based dosing 1
• Do not forget sodium supplementation in infants with primary adrenal insufficiency due to renal immaturity 2
• Do not exceed 20 mg/m²/day chronically without compelling indication due to growth suppression risk 2
• Be vigilant for candidal infections in premature infants receiving IV hydrocortisone, especially with central lines and antibiotics 4